US Stock MarketDetailed Quotes
ADAP Adaptimmune Therapeutics
- 0.797
- +0.020+2.57%
Close Nov 8 16:00 ET
- 0.800
- +0.003+0.39%
Post 20:01 ET
203.80MMarket Cap-2213P/E (TTM)
0.800High0.750Low687.53KVolume0.777Open0.777Pre Close529.70KTurnover0.40%Turnover RatioLossP/E (Static)255.75MShares2.05052wk High2.12P/B135.91MFloat Cap0.42052wk Low--Dividend TTM170.55MShs Float21.570Historical High--Div YieldTTM6.40%Amplitude0.420Historical Low0.770Avg Price1Lot Size
About Adaptimmune Therapeutics Company
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Company Profile
SymbolADAP
Company NameAdaptimmune Therapeutics
Listing DateMay 6, 2015
Issue Price17.00
Founded2008
CEOMr. Adrian Rawcliffe
MarketNASDAQ
Employees449
Securities TypeDR
ADS Ratio1.0 : 6.0
Fiscal Year Ends12-31
Address60 Jubilee Avenue,Milton Park
CityAbingdon
ProvinceOxfordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeOX14 4RX
Phone44-1235-430000
Websitehttp://www.adaptimmune.com
Company Executives
- Name
- Position
- Salary
- James J. Noble
- Chief Executive Officer and Director
- --
- Adrian Rawcliffe
- Director and Chief Executive Officer
- 2.77M
- William C. Bertrand, Jr
- Chief Operating Officer
- 1.22M
- Dr. Elliot Norry
- Chief Medical Officer
- 1.18M
- Cintia Piccina
- Chief Commercial Officer
- --
- Dr. Joanna Brewer
- Chief Scientific Officer
- --
- Gavin Hilary James Wood
- Chief Financial Officer and Principal Accounting Officer
- 1.17M
- Dr. Helen Tayton-Martin, PhD
- Chief Business and Strategy Officer
- 1.18M
- John Lunger
- Chief Patient Supply Officer
- --
- David M. Mott
- Chairman of the Board
- 174.83K
- Dr. Ali Behbahani, M.B.A.,M.D.
- Independent Director
- 111.54K
- John P. Furey
- Independent Director
- 117.25K
- Dr. Garry E. Menzel, PhD
- Independent Director
- 117.29K
- Lawrence M. Alleva
- Independent Director
- 128.80K
- Dr. Priti Hegde, PhD
- Independent Director
- 82.25K
- Dr. Andrew R. Allen, M.D.,PhD
- Independent Director
- 83.50K
- Dr. Kristen M. Hege, M.D.
- Independent Director
- 72.63K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
